Upload
ami-barker
View
214
Download
1
Embed Size (px)
DESCRIPTION
3 Traditional Approaches to Dissemination & Implementation of Clinical Trial Results Press release/press conference Short burst of media coverage Presentations at scientific meetings Publications in peer-reviewed journals
Citation preview
1
Dissemination and Implementation
Paul K. Whelton MD, MSc
for the
ALLHAT Collaborative Research Group
ALLHATU.S. Department of Health and Human
Services
National Institutes of Health
National Heart, Lung, and Blood Institute
22
Selected Factors that Influence Dissemination and Selected Factors that Influence Dissemination and Implementation of New Treatment Trial FindingsImplementation of New Treatment Trial Findings
System of CareSystem of Care– Access to careAccess to care– Insurance coverageInsurance coverage– Marketing influencesMarketing influences
ProviderProvider– KnowledgeKnowledge– ConvictionConviction– Recall of resultsRecall of results– Interest in innovationInterest in innovation– Marketing influencesMarketing influences
Patient levelPatient level– PreferencesPreferences– SymptomsSymptoms– Marketing influencesMarketing influences
ALLHAT
33
ALLHATTraditional Approaches to Dissemination& Implementation of Clinical Trial Results
Press release/press conference
Short burst of media coverage
Presentations at scientific meetings
Publications in peer-reviewed journals
44
Recommendations Lag Behind EvidenceRecommendations Lag Behind Evidence
19721972 10 RCTs; >2,500 patients.10 RCTs; >2,500 patients. Not recommended in anyNot recommended in any Benefit in Benefit in meta-analysis; meta-analysis; textbook/review articletextbook/review article p < 0.01p < 0.01
19821982 27 RCTs; >8,000 patients.27 RCTs; >8,000 patients. Only 1 of 13 Only 1 of 13 textbooks/reviewstextbooks/reviews Benefit in Benefit in meta-analysis;meta-analysis; (Special (Special settings only)settings only)
p < 0.001 p < 0.001
19861986 43 RCTs; >21,000 patients.43 RCTs; >21,000 patients. Only 7 of 10 Only 7 of 10 textbooks/reviewstextbooks/reviews Benefit in meta-analysis;Benefit in meta-analysis;
p < 0.00001p < 0.00001
Antman et al, JAMA 1992;268:240-248.
RecommendationsKnowledge
Use of Fibrinolytic Therapy Following Acute MI
55
Knowing is Not the Same as DoingKnowing is Not the Same as Doing
35%
7%
61%
76%
0% 20% 40% 60% 80% 100%
Visits with SBP< 150 mm Hg
Visits with SBP< 140 mm Hg
Satisfied withBP control
Aware, Agreewith JNC-VI?
Oliveria et al, Arch Intern Med 2002;162:413-420
Survey of 21 physicians and 270 associated patient visits
PhysicianReport
PhysicianPractice
66
ALLHATRationale for Dissemination & Implementation of the ALLHAT Results
Large body of important information
Provide strong scientific basis for clinical decision-making in pharmacotherapy of hypertension
Important that practitioners and public benefit from time, effort, resources and care devoted to conduct of ALLHAT
77
ALLHAT Approach to Dissemination & ALLHAT Approach to Dissemination & Implementation of Knowledge in Clinical PracticeImplementation of Knowledge in Clinical Practice
Dissemination & implementation into clinical Dissemination & implementation into clinical practice given priority statuspractice given priority statusDissemination Committee formedDissemination Committee formedConsultation with experts in disseminationConsultation with experts in disseminationImplementation planned in two phasesImplementation planned in two phases– InitialInitial– Long-termLong-term
ALLHAT
88
ALLHATDelineation of Core Messages
Because of the superiority of thiazide-type diuretics in preventing one or more major forms of CVD and their lower cost, they should be the drug of choice for first step antihypertensive therapy.
For the patient who cannot take a diuretic (which should be an unusual circumstance), CCB’s and ACEI’s may be considered.
Most hypertensive patients require more than one drug. Diuretics should generally be part of the antihypertensive regimen. Lifestyle advice should also be provided.
99
ALLHAT
Media training for national & regional Media training for national & regional spokespersons spokespersons Press conference & intensive media coveragePress conference & intensive media coveragePresentations & publicationsPresentations & publications– Research-oriented venuesResearch-oriented venues– Practice-oriented venuesPractice-oriented venuesGeneration & distribution of dissemination aidsGeneration & distribution of dissemination aids
Initial Strategies for Dissemination & Implementation in Clinical Practice
1010
ALLHAT
Pocket reference cardPocket reference card
Prototype letter to colleaguesPrototype letter to colleagues
Aid in identification of opinion leadersAid in identification of opinion leaders
Aid in creation of site specific Aid in creation of site specific dissemination plan dissemination plan
Web sites for easy access to Web sites for easy access to information and dissemination aidsinformation and dissemination aids
Study slidesStudy slides
Frequently asked Frequently asked questionsquestions– ProvidersProviders– Patients & publicPatients & public
Study newslettersStudy newsletters– ProvidersProviders– Study participantsStudy participants
Case studiesCase studies
Initial Strategies for Dissemination& Implementation in Clinical Practice
1111
ALLHATOngoing Strategies for Dissemination & Implementation in Clinical Practice
Provision of information for practice Provision of information for practice guidelines committeesguidelines committees
Continued facilitation of professional Continued facilitation of professional education opportunitieseducation opportunities– ALLHAT Steering Committee membersALLHAT Steering Committee members– ALLHAT investigatorsALLHAT investigators
Ongoing media coverageOngoing media coverage
1212
ALLHATPlanned Strategies for Dissemination& Implementation in Clinical Practice
Health care providersHealth care providers-- Face-to-face colleague contactFace-to-face colleague contact-- Physician contact through NHBPEP member Physician contact through NHBPEP member
organizationsorganizations
Formulary system approachFormulary system approach
Patient-oriented approach throughPatient-oriented approach through public service announcementspublic service announcements
1313
Results as of June 2004Results as of June 2004>240 presentations>240 presentations
ManuscriptsManuscripts-- 25 published25 published-- 48 in process48 in process
Distribution of Dissemination aidsDistribution of Dissemination aids– Main results, core messages, slides, newsletters, Main results, core messages, slides, newsletters,
and pocket cards distributed to more than 600 and pocket cards distributed to more than 600 clinical site investigators and through them to their clinical site investigators and through them to their colleagues in “Dear Colleague” letterscolleagues in “Dear Colleague” letters
– Frequently asked questions and newsletter Frequently asked questions and newsletter distributed to more than 42,000 participants distributed to more than 42,000 participants through clinical sitesthrough clinical sites
ALLHAT
1414
Results as of June 2004Results as of June 2004MediaMedia– Millions reached through print, radio, television, and Millions reached through print, radio, television, and
internet messagesinternet messages
WebsitesWebsites– ALLHATALLHAT
134,405 users134,405 users2,872,734 hits2,872,734 hits
– NHLBINHLBI– NHBPEP Coordinating Committee member NHBPEP Coordinating Committee member
organizationsorganizations
Guidelines AssistanceGuidelines Assistance– NHLBI JNC 7NHLBI JNC 7– Canadian BP GUIDELINESCanadian BP GUIDELINES– NKF GUIDELINESNKF GUIDELINES
ALLHAT
1515
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
35,000,000
Q1-02 Q2-02 Q3-02 Q4-02 Q1-03 Q2-03 Q3-03
ACEIs TotalACEIs Total
CCBs TotalCCBs Total
Diur TotalDiur Total
Tota
l Pr
escr
iptio
nsTo
tal
Pres
crip
tions
ALLHATIMS Health, National Prescription Audit, 2003IMS Health, National Prescription Audit, 2003
Drug Utilization by ClassDrug Utilization by Class
2002 2003
1616
SummarySummary
Traditional strategies for dissemination and Traditional strategies for dissemination and implementation of clinical trial results have had limited implementation of clinical trial results have had limited and delayed impact on clinical practiceand delayed impact on clinical practice
ALLHAT has utilized a new proactive approach to ALLHAT has utilized a new proactive approach to dissemination and implementation of its findingsdissemination and implementation of its findings
Success in influencing antihypertensive treatment Success in influencing antihypertensive treatment decisions is being evaluateddecisions is being evaluated
Experience to date suggests success in achieving our Experience to date suggests success in achieving our objectivesobjectives
ALLHAT